(NGVT) Ingevity - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US45688C1071
NGVT: Activated Carbon, Specialty Chemicals, Engineered Polymers
Ingevity Corporation (NYSE: NGVT) is a specialty chemicals company with a diversified portfolio of high-performance products. The company operates globally, serving customers across North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. Its business is organized into three distinct segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.
The Performance Materials segment is a leader in activated carbon products, with a focus on automotive applications. It engineers hardwood-based and chemically activated carbon solutions for gasoline vapor emission control systems in vehicles, including cars, trucks, motorcycles, and boats. Beyond automotive, this segment also supplies activated carbon for purification in food, water, beverage, and chemical industries.
The Performance Chemicals segment is divided into two main areas: road technologies and industrial specialties. Its products are critical in pavement construction, preservation, and recycling, as well as road markings. Additionally, this segment serves industrial markets with agrochemical dispersants, paper chemicals, and other specialty applications.
The Advanced Polymer Technologies segment specializes in caprolactone and caprolactone-based polymers. These materials are used in a wide range of applications, including coatings, resins, elastomers, adhesives, bioplastics, and medical devices. This segment’s products are particularly valued for their versatility and performance in demanding environments.
Originally part of WestRock Company as its Specialty Chemicals Business, Ingevity Corporation was spun off and rebranded in September 2015. Founded in 1964, the company is headquartered in North Charleston, South Carolina, and has established itself as a trusted supplier to automotive parts manufacturers and other industrial customers worldwide. Its global reach and diversified product portfolio make it a key player in the specialty chemicals industry.
From a financial perspective, Ingevity Corporation has a market capitalization of approximately $1.591 billion USD. The stock trades on the NYSE under the ticker symbol NGVT. With a forward P/E ratio of 9.97 and a price-to-book ratio of 7.22, the company offers investors a blend of growth and stability in the specialty chemicals sector. Its price-to-sales ratio of 1.08 reflects its strong revenue generation capabilities.
Additional Sources for NGVT Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NGVT Stock Overview
Market Cap in USD | 1,444m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception | 2016-05-02 |
NGVT Stock Ratings
Growth 5y | -20.7% |
Fundamental | -26.2% |
Dividend | 0.0% |
Rel. Strength | -10.9 |
Analysts | 3.75/5 |
Fair Price Momentum | 35.53 USD |
Fair Price DCF | 32.34 USD |
NGVT Dividends
No Dividends PaidNGVT Growth Ratios
Growth Correlation 3m | -2.7% |
Growth Correlation 12m | -21.3% |
Growth Correlation 5y | -56.9% |
CAGR 5y | 0.55% |
CAGR/Max DD 5y | 0.01 |
Sharpe Ratio 12m | -0.37 |
Alpha | -29.40 |
Beta | 1.531 |
Volatility | 49.13% |
Current Volume | 163.9k |
Average Volume 20d | 202.3k |
As of April 03, 2025, the stock is trading at USD 39.54 with a total of 163,883 shares traded.
Over the past week, the price has changed by -8.73%, over one month by -12.60%, over three months by +0.00% and over the past year by -14.36%.
Probably not. Based on ValueRay Fundamental Analyses, Ingevity (NYSE:NGVT) is currently (April 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -26.22 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NGVT as of April 2025 is 35.53. This means that NGVT is currently overvalued and has a potential downside of -10.14%.
Ingevity has received a consensus analysts rating of 3.75. Therefor, it is recommend to hold NGVT.
- Strong Buy: 1
- Buy: 1
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, NGVT Ingevity will be worth about 39.1 in April 2026. The stock is currently trading at 39.54. This means that the stock has a potential downside of -1.01%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 58.5 | 48% |
Analysts Target Price | 54.3 | 37.2% |
ValueRay Target Price | 39.1 | -1% |